PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers

被引：2
|
作者：
Stebbing, Justin [1 ]
Ellis, Paul [2 ,3 ]
Tutt, Andrew [4 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Oncol & Surg, London W12 0NN, England
[2] Guys & St Thomas NHS Trust, Dept Oncol, London, England
[3] Kings Coll Hosp, London, England
[4] Guys Hosp, Breakthrough Breast Canc Res Unit, Kings Hlth Partners AHSC, London SE1 9RT, England
来源：
FUTURE ONCOLOGY | 2010年 / 6卷 / 04期
关键词：
breast cancer; BRCA; PARP inhibitor; triple negative; POLY(ADP-RIBOSE) POLYMERASE; RESISTANCE; DNA; REPAIR; MUTATIONS; TUMORS; BRCA1;
D O I：
10.2217/FON.10.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [41] PARP Inhibitors for Breast Cancer: Germline BRCA1/2 and Beyond
    Menezes, Maria Clara Saad
    Raheem, Farah
    Mina, Lida
    Ernst, Brenda
    Batalini, Felipe
    CANCERS, 2022, 14 (17)
  • [42] Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer
    Valiente, Consolacion Molto
    Amir, Eitan
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (07) : 1887 - 1890
  • [43] Cross-species comparison of aCGH data from mouse and human BRCA1- and BRCA2-mutated breast cancers
    Holstege, Henne
    van Beers, Erik
    Velds, Arno
    Liu, Xiaoling
    Joosse, Simon A.
    Klarenbeek, Sjoerd
    Schut, Eva
    Kerkhoven, Ron
    Klijn, Christiaan N.
    Wessels, Lodewyk F. A.
    Nederlof, Petra M.
    Jonkers, Jos
    BMC CANCER, 2010, 10
  • [44] PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Geenen, Jill J. J.
    Linn, Sabine C.
    Beijnen, Jos H.
    Schellens, Jan H. M.
    CLINICAL PHARMACOKINETICS, 2018, 57 (04) : 427 - 437
  • [45] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Glodzik, Dominik
    Bosch, Ana
    Hartman, Johan
    Aine, Mattias
    Vallon-Christersson, Johan
    Reutersward, Christel
    Karlsson, Anna
    Mitra, Shamik
    Nimeus, Emma
    Holm, Karolina
    Hakkinen, Jari
    Hegardt, Cecilia
    Saal, Lao H.
    Larsson, Christer
    Malmberg, Martin
    Ryden, Lisa
    Ehinger, Anna
    Loman, Niklas
    Kvist, Anders
    Ehrencrona, Hans
    Nik-Zainal, Serena
    Borg, Ake
    Staaf, Johan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [46] Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
    Vencken, P. M. L. H.
    Kriege, M.
    Hoogwerf, D.
    Beugelink, S.
    van der Burg, M. E. L.
    Hooning, M. J.
    Berns, E. M.
    Jager, A.
    Collee, M.
    Burger, C. W.
    Seynaeve, C.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1346 - 1352
  • [47] Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study
    van Barele, Mark
    Rieborn, Amy
    Heemskerk-Gerritsen, Bernadette A. M.
    Obdeijn, Inge-Marie
    Koppert, Linetta B.
    Loo, Claudette E.
    Tollenaar, Rob A. E. M.
    Ausems, Margreet G. E. M.
    van de Beek, Irma
    Berger, Lieke P., V
    de Boer, Maaike
    van Hest, Liselot P.
    Kets, C. Marleen
    Rookus, Matti
    Hebon
    Schmidt, Marjanka K.
    Jager, Agnes
    Hooning, Maartje J.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (01) : 159 - 170
  • [48] Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study
    Mark van Barele
    Amy Rieborn
    Bernadette A. M. Heemskerk-Gerritsen
    Inge-Marie Obdeijn
    Linetta B. Koppert
    Claudette E. Loo
    Rob A. E. M. Tollenaar
    Margreet G. E. M. Ausems
    Irma van de Beek
    Lieke P. V. Berger
    Maaike de Boer
    Liselot P. van Hest
    C. Marleen Kets
    Matti Rookus
    Marjanka K. Schmidt
    Agnes Jager
    Maartje J. Hooning
    Breast Cancer Research and Treatment, 2022, 194 : 159 - 170
  • [49] Triple-negative breast cancer arising in a fibroadenoma in BRCA 1 mutated patient
    Brunetti, Nicole
    Valente, Irene
    Pitto, Francesca
    Calabrese, Massimo
    JOURNAL OF MEDICAL ULTRASOUND, 2023, 31 (01) : 63 - 65
  • [50] Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
    Lee, Chee Khoon
    Scott, Clare
    Lindeman, Geoffrey J.
    Hamilton, Anne
    Lieschke, Elizabeth
    Gibbs, Emma
    Asher, Rebecca
    Badger, Heath
    Paterson, Robin
    Macnab, Lauren
    Kwan, Edmond Michael
    Francis, Prudence A.
    Boyle, Frances
    Friedlander, Michael
    BRITISH JOURNAL OF CANCER, 2019, 120 (03) : 279 - 285
12345